Abstract
Aim: To determine the usefulness of serum cystatin-C along with vascular endothelial growth factor (VEGF) as an early marker of diabetic nephropathy. Method: The study includes diabetic patients visiting the Medicine OPD and was divided into groups according to duration of diabetes. Group 1 with diabetes between 5-10 years, group 2 with diabetes between 10-15 years, group 3 with diabetes more than 15 years and control group. Results: Serum cystatin-C and VEGF level raised significantly in group 2 patients (10-15 years duration) and increases further with the progression of disease. Conclusion: Both cystatin-C and vascular endothelial growth factor can be useful marker of early diabetic nephropathy in patients with type 2 diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Advanced Biochemistry Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
